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Abstract
Pre-exposure prophylaxis (PrEP) is an effective HIV prevention strategy. Few studies have explored adolescents and young 
people’s perspectives toward PrEP. We conducted 24 group discussions and 60 in-depth interviews with males and females aged 
13–24 years in Uganda, Zimbabwe, and South Africa between September 2018 and February 2019. We used the framework 
approach to generate themes and key concepts for analysis following the social ecological model. Young people expressed a 
willingness to use PrEP and identified potential barriers and facilitators of PrEP uptake. Barriers included factors at individual 
(fear of HIV, fear of side effects, and PrEP characteristics), interpersonal (parental influence, absence of a sexual partner), com-
munity (peer influence, social stigma), institutional (long waiting times at clinics, attitudes of health workers), and structural 
(cost of PrEP and mode of administration, accessibility concerns) levels. Facilitators included factors at individual (high HIV 
risk perception and preventing HIV/desire to remain HIV negative), interpersonal (peer influence, social support and care for 
PrEP uptake), community (adequate PrEP information and sensitization, evidence of PrEP efficacy and safety), institutional 
(convenient and responsive services, provision of appropriate and sufficiently resourced services), and structural (access and 
availability of PrEP, cost of PrEP) levels. The findings indicated that PrEP is an acceptable HIV prevention method. PrEP 
uptake is linked to personal and environmental factors that need to be considered for successful PrEP roll-out. Multi-level 
interventions needed to promote PrEP uptake should consider the social and structural drivers and focus on ways that can 
inspire PrEP uptake and limit the barriers.
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Introduction
Pre-exposure prophylaxis (PrEP) is a promising and effective 
HIV prevention strategy, utilizing antiretroviral (ARV) medi-
cation taken as a single oral pill to prevent the acquisition of 
HIV (Golub, Gamarel, & Surace, 2017). The World Health 
Organization (WHO, 2012) approved PrEP as an additional 
biomedical prevention strategy and released guidelines for 
PrEP use among particular groups of people, i.e., sero-dis-
cordant couples and men who have sex with men (MSM). 
More recently, the WHO has broadened the recommenda-
tion to include all groups at substantial risk of HIV infection 
(World Health Organization, 2015).
Adolescents and young people (AYP) aged 15–24 years 
account for approximately 30% of all new HIV infections 
worldwide with adolescent HIV most prevalent in Africa 
(Joint United Nations Programme on HIV/AIDS, 2015; 
Rotheram-Borus, Davis, & Rezai, 2018). This could be attrib-
uted to the multiple co-occurring transitions during adoles-
cence such as increased autonomy, decreased adult supervi-
sion, identity formation, peer influence, and social transition, 
potentially leading to early sexual debut and health risk behav-
iors that may lead to HIV infection (Cicchetti & Rogosch, 
2002; Schulenberg, Maggs, & Hurrelmann, 1999). Despite 
this, the levels of PrEP acceptability and uptake among AYP 
in sub-Saharan Africa remain unclear, as research on PrEP has 
focused on high-risk adult populations (Bärnighausen et al., 
2019; Shah, Gillespie, Holt, Morris, & Camacho-Gonzalez, 
2019; Vaughn, Dillon, & Kedia, 2019; World Health Organi-
zation, 2017b). Previous work among MSM showed that 
stigma, drug effects, and adherence were among the barriers 
to PrEP uptake (Holloway et al., 2017; Owens et al., 2020), 
while a facilitator of uptake was the provision of PrEP free of 
charge (Golub et al., 2017). These barriers and facilitators did 
not differ in the population of women and populations most 
at risk in East Africa and other countries (Amico et al., 2017; 
Mack, Odhiambo, Wong, & Agot, 2014; Thigpen et al., 2012; 
Young, Flowers, & McDaid, 2014).
As part of the strategies to attain the 95-95-95 fast-track 
action to end the AIDS epidemic by 2030, engaging AYP 
in the co-creation of HIV prevention strategies, including 
PrEP, needs to be rapidly adopted in sub-Saharan settings 
such as Uganda, Zimbabwe, and South Africa with growing 
AYP populations to successfully reduce the epidemic (United 
Nations, 2012; United Nations General Assembly, 2016; 
World Health Organization, 2017a). This is critical as many 
of these countries have large adolescent populations at high 
risk of HIV infection with high HIV incidence rates (Baeten 
et al., 2012; Shisana et al., 2014; World Health Organization, 
2012). In this study, we sought to explore the barriers and 
facilitators of uptake of PrEP among AYP, to help formulate 
and inform PrEP implementation activities for this age group. 
This will support the development of cultural-, age-, and gen-
der-appropriate risk reduction understanding for adolescents 
and young people 13–24 years at risk of HIV acquisition.
Theoretical Orientation
A growing body of literature shows that health outcomes are 
increasingly influenced by the environments within which 
individuals live and less by individual behavior (Busza et al., 
2012; Feldacker, Ennett, & Speizer, 2011; Krieger, 2001). 
We therefore adopted the social ecological model (SEM) as a 
theoretical framework for analysis. The SEM has five interde-
pendent levels that offer a holistic approach to understanding 
how individual, interpersonal, community, organizational, 
and structural factors influence health behaviors (McLeroy, 
Bibeau, Steckler, & Glanz, 1988; Stokols, 1996), including 
those associated with HIV prevention (Batchelder, Gonzalez, 
Palma, Schoenbaum, & Lounsbury, 2015; Joore, van Roos-
malen, van Bergen, & van Dijk, 2017; Kaufman, Cornish, 
Zimmerman, & Johnson, 2014). The first level refers to indi-
vidual factors that facilitate or inhibit a person’s choices, 
including personal stigma, fear of HIV, and personal adher-
ence challenges. The second level is interpersonal/network 
influences. An individual’s relationship with their closest 
social peers, partners, and family members influences the 
AYP’s uptake of PrEP. The third level is community perspec-
tives, as young people are influenced by community-held 
fears of PrEP side effects, and myths and misconceptions. 
The fourth level refers to health system (institutional) influ-
ences, including busy, unapproachable health workers and 
long waiting times at clinics. The final level refers to struc-
tural influences including the accessibility of PrEP, and long 
distances to clinics and school. AYP operate within these 
structures, and their choices are based on their motivations 
and interests (Barnett, Seeley, Levin, & Katongole, 2015; 
Kaufman et al., 2014).
Drawing upon the SEM framework, we offer theoretically 
informed insights regarding the potential barriers and facili-




This study was part of the Combined HIV Adolescent PrEP 
and Prevention (CHAPS) study evaluating the acceptability 
and feasibility of providing daily and on-demand PrEP to ado-
lescent boys and girls in the three countries (South Africa, 
Uganda, and Zimbabwe) conducted between September 
2018 and February 2019. We conducted 24 group discus-
sions (GDs) with 6–8 participants (8 per country; 4 for each 
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gender) and 60 in-depth interviews (IDIs) (20 per country) 
stratified by age (13–17 and 18–24 years) and gender (males 
and females) to enhance the possibility of open discussion 
among young people of the same age and gender.
Krueger (2014) recommends GDs consisting of 6–8 par-
ticipants when conducting discussions on topics that are 
non-sensitive in order to encourage information generation 
through group participants interaction. As a method of data 
collection, GDs encourage open, interactive discussion of 
shared norms, beliefs and common knowledge. However, 
GDs inherently facilitate in-depth discussion of individual 
standpoints within the context of other group members and 
may over represent opinions of participant(s) dominating the 
discussion (Krueger, 2014). We therefore conducted IDIs in 
order to increase reliability of our data.
One-to-one IDIs with a small number of AYP were con-
ducted to obtain thick in depth descriptions and valuable 
insights about the barriers and facilitators to PrEP uptake. 
These interviews were conducted to provide further context, 
perspectives and more detailed information alongside the 
FGD data. IDIs were helpful to obtain information from AYP 
who may be uncomfortable sharing their honest feelings in 
the group setting (Ritchie, Lewis, Nicholls, & Ormston, 
2013).
GDs and IDIs were conducted by a gender matched mod-
erator to guide the data collection process as a formative 
evaluation means to explore AYP’s barriers and facilitators of 
PrEP uptake. Participants were recruited through purposive 
community sampling with the help of community mobilisers. 
The IDIs and GDs were held in a conducive place that was 
safe, neutral and with minimal distractions for the partici-
pants and the researchers. The demographic composition of 
the study participants is presented in Table 1.
At the time of the study in 2018/2019, Uganda had not 
rolled out PrEP to the general population, while in Zimba-
bwe, PrEP for AYP was only available at selected sites with 
one such site within the study recruitment area, and for South 
Africa PrEP was available to selected high-risk groups. Most 
participants were PrEP-naïve, and PrEP was not readily avail-
able to young people in the three countries. Most participants 
received information about PrEP for the first time during 
mobilization and implementation of this research.
Procedure
Experienced social science researchers conducted the GDs 
and IDIs, using a semi-structured topic guide (Appendix A in 
electronic supplementary materials), in a secure and private 
location that was comfortable for the interviewer and the 
interviewee. This place was either suggested by the inter-
viewee or preset by the interviewer at the local health clinic 
or community hall. The IDIs and GDs generally focused on 
motivations and hindrances for HIV testing, PrEP preference 
(daily vs on-demand), and barriers and facilitators of PrEP 
uptake. Data collection was conducted in a language comfort-
able to the participant, audio-recorded, transcribed verbatim 
and later translated into English.
Participants provided written informed consent for those 
above 18 years, and written assent and parental consent for 
those below 18 years. A waiver of parental consent was 
obtained for emancipated minors according to national guide-
lines from the regulatory authorities in the three countries. 
Participants were reimbursed for their time and participation 
in the study according to site-specific guidelines.
Data Analysis
A framework approach using the SEM was used for data 
analysis (Gale, Heath, Cameron, Rashid, & Redwood, 
2013). To achieve data familiarization, the researchers at 
each site read the transcripts several times and made notes 
of key ideas and recurrent codes. Four transcripts were 
initially coded to identify emerging and recurrent themes 
which were compared across sites to ensure consistency 
and refine the coding framework and codebook. It is at 
this point that all the remaining transcripts were coded 
using the refined codebook. Data were then indexed by 
identifying segments of the data that corresponded to a 
particular code.
The research teams discussed mapping and interpreta-
tion of the data to develop broader categories allowing 
Table 1  Demographic 
characteristics of study 
participants
Variable In-depth interviews Group discussions
Females (n = 31) Males (n = 29) Females (n = 84) Males (n = 83)
Age in years
 Mean (SD) 18.23 (3.262) 17.58 (3.166) 18.26 (3.732) 18.64 (3.604)
Education
 Primary and below 08 08 21 12
 Secondary 14 15 45 48
 Tertiary 03 03 05 13
 Preferred not to share 06 02 13 10
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them to distil the meaning of the data in context according 
to each research question. We present the overall analysis 
of data from the GDs and IDIs without country-specific 
analysis.
Results
The majority of participants at the three sites were single, 
had attained secondary-level education, and those out of 
school were either running a commercial business, or casu-
ally employed (involved in menial jobs requiring minimal 
skills with no regular work pattern or, formal employment) 
and a few were unemployed. We found common barriers and 
facilitators to PrEP uptake at multiple levels from the three 
countries as presented below.
Barriers to PrEP Uptake Among Adolescents 
and Young People
(a) Individual-level barriers
From the IDIs and GDs we found the following individual-
level barriers to PrEP uptake: PrEP-related stigma, pill bur-
den, doubting PrEP efficacy, the complexities of the timing, 
and schedule of taking PrEP and PrEP characteristics.
Stigma Related to PrEP Uptake
The participants mentioned that they would refrain from tak-
ing PrEP because of the association of PrEP with antiretro-
viral drugs and HIV-related stigma. This was a key barrier 
to uptake as participants linked taking daily tablets to people 
living with HIV. Thus, taking medication, especially daily, 
can be mistaken for taking ARVs for treatment rather than for 
prevention. HIV-related stigma and stigma associated with 
being promiscuous were concerns raised.
There is a fear that people will think you are already 
HIV positive and you are taking ART because many 
people do not have enough information about PrEP. 
(IDI Male 22 years; Zimbabwe)
And [stigma] will make young people feel outcasts 
within the community because people will say that you 
are lying by saying that this thing [PrEP] is to prevent. 
We know you are already infected, that is what would 
discourage them...You know rumors spread faster than 
the truth...as soon as one person thinks that PrEP is for 
sick people then that’s what everyone will think. (GD 
Females 18–24 years, South Africa)
AYP suggested that they would take PrEP in secret so 
nobody would see them and where there is limited privacy, 
taking PrEP would become difficult. Participants also men-
tioned that they would not disclose their PrEP use to their 
peers, for fear of being talked about.
You have to hide. Sometimes you may go with your 
friends to the club and get a man. You may fear to 
take that PrEP because your friends are around or you 
may fear to take PrEP because your friends may think 
that you are promiscuous. (GD Females 20–24 years; 
Uganda)
PrEP Pill Burden
Most of the participants expressed a fear of taking many 
tablets and thought that they would reach a time when they 
could no longer take the PrEP pills. It is at this point that 
participants gave scenarios to illustrate the circumstances 
that might make it hard for somebody to adhere to PrEP, such 
as already having other medications to take:
Some people have other illnesses. You may find one 
has to take medicines for pressure or diabetes. So if you 
add them PrEP, it may be a burden to her. (IDI Female 
18 years; Uganda)
Pill fatigue created by taking PrEP tablets daily when 
you are not sick was a concern raised by participants as a 
barrier to PrEP uptake. This also has implications for PrEP 
adherence.
When you have HIV, you take ARVs daily. It feels the 
same any way you take PrEP every day. You take PrEP 
pills like you are sick but you are not sick…Some won’t 
want it [PrEP] because they are lazy to take pills, more 
so taking pills every day. (GD Males, 13–17 years; South 
Africa)
The AYP in our study associated taking medication with 
treatment or as a cure for a condition, rather than prevention. 
For some, taking medicine when healthy was thought to be 
strange. Other participants mentioned that they had a general 
dislike for swallowing pills, preferring injections, and this 
would be a barrier to adhering to oral PrEP:
Some can refuse PrEP because they do not like pills 
generally. Others don’t like to take pills on a daily basis 
especially when not ill and cannot cope with the pills 
so considering this some people can refuse them [PrEP 
pills]. (IDI Female 24 years; Zimbabwe)
Doubting PrEP Effectiveness
Some participants raised doubts about the effectiveness 
of PrEP to prevent HIV infection and this was viewed as 
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a potential barrier to uptake. Although there were partici-
pants who recognized the usefulness of PrEP as prophylaxis 
to prevent HIV if it worked, many were skeptical about its 
effectiveness:
Most HIV drugs are under investigation in clinical trials 
and most of them are found not to be effective when the 
trials are complete that is why I am still doubting PrEP 
effectiveness. Those of us who have received informa-
tion about PrEP shall share it with others when we go 
back […] some can only accept PrEP after understand-
ing its effectiveness but if not, they can’t accept it. (GD 
Males 18–24; Uganda)
What am I afraid of is that you see PrEP may not be 
working, it may not work effectively and may make the 
HIV situation worse, you see. (IDI Female 13 years; 
South Africa)
Complexities of Timing of Taking PrEP
There was a perception that daily PrEP would require strin-
gent time keeping and maintaining a regular routine. Some 
AYP explained that sexual activity was not necessarily 
planned with such regularity.
…at times you might be with your boyfriend and you 
left the pills at home and you want to have sex right 
there and then and you weren’t taking PrEP every day 
and it becomes difficult. (GD Females 19–21 years; 
Zimbabwe).
Participants also mentioned that some jobs are demand-
ing and may not allow time to collect their medication or 
they may forget to take it. Some expressed concerns about 
unplanned work activities and the consequences if they 
missed their PrEP dose and engaged in sexual activity.
I think it won’t be easy for most people to use it [PrEP] 
because the nature of their jobs doesn’t give them 
time…A person may be having a lot of things to do and 
he/she forgets to take it yet you don’t know when you 
are going to have sex. (GD Males 13–17 years; Uganda)
PrEP Characteristics
The concerns about PrEP tablets included the taste, smell, 
size, and possible side effects of the tablets.
Odor and Taste of the Pill
Some participants expressed the view that the odor and taste 
of the pill may be a barrier to PrEP uptake. Participants said 
that a pill with no smell would be more acceptable.
I might swallow PrEP and it causes my tongue to taste 
like everything is sour or whatever I eat [afterwards] 
to taste sour…I do not want sour pills and that would 
stop me from taking PrEP. (GD Females 13–17 years; 
Uganda)
…when I take a pill every time, like if I take 1 pill 
for 5 days or 7 days, for me the taste changes. It starts 
having a bad taste, a bitter taste which I don’t like 
and if PrEP causes it that will be the end. (GD Males 
13–17 years; South Africa)
Most participants said that if the pill was bitter/sour, they 
were unlikely to take it, irrespective of its effectiveness. Spe-
cifically, some participants made suggestions for pills that 
would be acceptable to them:
If PrEP is not bitter because something bitter is always 
problematic and PrEP tablets they bring are sweet and 
chewable. I can take it for even a year or three…bitter 
tablets are very problematic and not for me. (IDI Male 
17 years; Uganda)
Size of the Pill
Several participants expressed a fear of the discomfort of 
swallowing large PrEP tablets and thought they should break 
the tablets into two for easy swallowing. For some, the per-
ception and the concern was that large tablets could cause 
choking and eventually kill someone.
The problem will arise if the tablets brought are big in 
that when you swallow it can choke you and you die. 
(GD Males 13–17 years; Uganda)
I even told the doctors that for me it’s hard to swallow 
the pill because I am not used to bigger pills, I am used 
to smaller pills. (IDI Female 22 years; South Africa)
Side Effects of the Pills
Participants expressed a fear of the unknown consequences of 
taking PrEP, ranging from general body weakness to lowered 
sexual performance. These fears were based on information 
they had gained from discussion in their communities which 
fed their fears.
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Feeling drowsy…Fatigue, and…Being lazy like doing 
nothing and always sleeping. Yeah. I am scared of 
things like that or maybe let’s say it gets to my testicles 
and does things that [unclear], you see? Cos I’m very 
careful towards my sperm. (GD Males 13–17 years; 
South Africa)
Other narratives revealed concerns about side effects 
related to skin irritation and ulcers leading to skin and stom-
ach cancers.
There are some drugs you swallow and they bring 
“ebirogologo” [skin reactions/rash], so am concerned 




Participants expressed fear that their parents would find 
out that they were taking PrEP and therefore know they 
are sexually active. Sex at a young age (especially before 
marriage) is disapproved of in most sub-Saharan African 
cultures, and participants under the direct care of their par-
ents revealed they would not take PrEP for fear of their 
parents discovering the pills.
The issue is on taking tablets every day and living with 
your parents. Where would I keep the tablets where 
they will not find them? If they come across them, it 
will be disaster at home. They will start saying let’s go 
to the hospital if you are sick. (GD Males 16–18 years; 
Zimbabwe).
I might accept to take PrEP but my parents might 
discourage me from taking it thinking I may engage 
in risky sex. Sometimes the women might discourage 
their husbands to take PrEP fearing they may go and 
have sex with other women yet the men are willing to 
use it. (GD Males 19–24 years; Uganda)
Absence of a Sexual Partner or Faithfulness
The absence of a sexual partner and not being in long-term 
relationships were viewed by some participants as a barrier 
to PrEP uptake, as there would be no reason to take PrEP 
daily when there was no plan for sexual activity. Some of 
the participants who had partners and were choosing to 
be faithful to one sexual partner mentioned they would 
have no reason to take PrEP. These could potentially affect 
uptake and adherence to PrEP.
(c) Community-level barriers
Myths and Misconceptions
Some participants confused PrEP with Post-Exposure 
Prophylaxis (PEP) and, in addition, did not understand how 
it could work to prevent infection. For example, there was 
a misconception about the dangers of taking medication 
when you are well.
When you take medicine when you are not sick, the 
medicine becomes poisonous in your life. Some may 
say if you are taking PrEP, you are taking poison 
which may bring you other illnesses. Therefore, you 
may find yourself leaving the medicine [PrEP]… (IDI 
Female 18 years; Uganda)
Furthermore, information from friends and peers was a 
key source of misconceptions yet they were their primary 
source of knowledge and support. When friends and peers 
disapproved of PrEP use, it was perceived as being unlikely 
to be used.
I think the youth of today, what would discourage them 
is that they value their friend’s opinion the most. So a 
person would tell a friend “I am taking such and such, 
pills [PrEP] and then the friend would say why are you 
taking this thing?” You see. So it is as if they are held 
by peer pressure. A person can’t do anything for him/
herself, they do it to please others, before they do any-
thing, they first seek the approval of their friends and 
if negative, they stop. (GD Males, 18–24 years; South 
Africa)
Parents were not favored as a source of knowledge because 
young people believed their parents would link PrEP to sex-
ual initiation and early engagement in sexual activity. Some 
believed that some parents would perceive the introduction 
of PrEP to their children through the research project as a 
gateway to engage in risky sexual behavior.
Misconceptions About PrEP Use
Participants associated PrEP with many “terms and condi-
tions” required to take the drug. By taking PrEP, they antici-
pated that one should have enough money to buy everything 
their body demands, including ensuring that they eat well 
when taking the medication.
Like maybe I wake up in the morning then I am late, I 
must go to school, I don’t even eat food, obvious if you 
take, you must eat first isn’t it before taking pills. (IDI 
Male 16 years; South Africa)
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The other thing I know, some people may not get the 
diet required to take the medication. At times you can 
be feeding poorly; eating “kikomando” [beans and 
chapattis] yet it seems it requires eating well [having a 
balanced diet]. (IDI Male 19 years; Uganda)
In the Ugandan context, “eating well” is equated to eating 
a variety of expensive foods like Matooke [banana], rice, 
chicken, meat, fish, milk, fruits and vegetables. In contrast, 
eating beans and chapattis (flour, water and oil pancakes) sug-
gests consuming a less nutritious and inexpensive diet. Some 
participants mentioned they would not take PrEP because 
they were unable to meet dietary requirements. Young people 
mentioned other medicines like antimalarial prophylaxis and 




Stock-out of medicine from the health facilities was 
reported as a potential barrier (this was mentioned most 
frequently in Uganda). Participants commented that health 
facilities lack essential medicines, and when people go to 
the health facilities, there is nothing available, and they are 
advised to buy from expensive private pharmacies. This 
discourages them from taking medicine.
What may make it difficult for one to use PrEP is 
when she goes to the hospital to get PrEP and they 
tell her that it’s not available or when they tell her to 
come back another day. (GD Females 20–24 Years; 
Uganda)
What if it [stock-out] happens for PrEP remember 
since I have been taking the daily…, let’s say I am 
taking my PrEP daily and then it happens that now I 
am out on pills, there are no pills [at the clinic or PrEP 
dissemination point]. This is going to ruin my cycle 
[of taking pills/adherence]. (GD Males 18–24 years; 
South Africa).
Long Waiting Times at the Clinics/Busy Health 
Workers
Participants revealed that they preferred quick access to 
PrEP without having to spend long hours in queues waiting 
to receive PrEP. Instances when facilities are busy and they 
are required to wait for a long time was seen as a barrier 
to using PrEP.
The problem is the doctor may be attending to people 
slowly and yet there are many patients. I don’t want to 
sit there waiting to get a service so I will just give up 
and leave. Other people join in and the lines become 
long. (IDI Male 17 years; Uganda).
Attitude and Behaviors of Health Workers
Some of the participants were concerned about the attitude 
of health workers when they are seeking services. This was 
viewed as a major barrier because they thought if the health 
workers are rude to the clients, they might not find it condu-
cive to collect PrEP. Some, especially younger participants, 
feared that if those dispensing the medication are known to 
them, they might talk about them in the community to the 
extent of reporting them to their parents.
At times, the manner of approach and how they 
[health workers] explain things to you when they 
give you something, they are very judgmental. They 
don’t respectfully ask you questions nor do they make 




Most participants were concerned that if PrEP was not free 
they will not manage to buy it because most participants had 
an unstable source of income:
I think there are two reasons that would make my 
friends fail to take PrEP. The first reason is, if it is to be 
priced, he may fail to buy it from the shop. (GD Males 
13–17 years; Uganda)
People would want to take the pills, but the cost of the 
pills may be a barrier. Some pharmacies want US Dol-
lars for the pill and one may not afford it, that’s another 
challenge. (GD Females 19–21 years, Zimbabwe).
Mode of Administration
Participants shared their fear of taking tablets daily and would 
prefer an injection, implants or syrups. As oral PrEP would 
be the most accessible and easy to administer, participants 
acknowledged its limitations and expressed a preference for 
long-acting PrEP options such as injections and implants.
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For me on demand is tricky because at times you might 
be with your boyfriend and you left the pills at home 
and you want to have sex right there and then and you 
weren’t taking PrEP every day and it becomes diffi-
cult. So, the best option would be getting an injection 
in advance like for 6 months, that will be better. (GD 
Females 19–21 years; Zimbabwe).
Some, however, did not want to take anything:
Even if you just bring tablets and put them there, I just 
vomit. Some may fear to take PrEP tablets and say that 
“I rather fall sick with the thing [HIV] than taking those 
tablets.” (GD Females 13–17 years; Uganda)
Accessibility Concerns
Participants noted that if the access point for PrEP is not 
within easy reach, they might find it a problem to take PrEP. 
This was viewed in terms of points being far away from the 
users and requiring transport and time.
What may make it difficult for me to take PrEP, in case 
they decide to put PrEP in [the hospital] and we all 
have to get PrEP from there and when a person wants 
to go there it can cost around ten thousand shillings 
which I don’t have, then I wouldn’t go. (GD Females 
20–24 years, Uganda)
Facilitators to PrEP Uptake Among AYP
(1) Individual-level facilitators
From the IDIs and GDs, we identified two individual-level 
facilitators: (a) high HIV risk perception and (b) preventing 
HIV acquisition and desire to remain HIV negative.
High HIV Risk Perception
Some of the participants mentioned that perceiving them-
selves as being at risk of contracting HIV was a key facilitator 
to PrEP uptake. They mentioned that aspects like not know-
ing the HIV status of one’s partner, dislike and fear of going 
for an HIV test by their partners, created a fear of becoming 
infected. The introduction of PrEP was therefore viewed as 
an opportunity to reassure someone that they are protected 
and will not be infected.
Haa PrEP will make me feel comfortable because 
whenever I have sex I begin to worry whether my part-
ner has transmitted to me the virus which causes a lot 
of stress. With PrEP I will be certainly sure that all is 
well. (IDI Male 19 years; Zimbabwe)
Distrust of a partner and the increased chance of acquiring 
HIV were reported as a motivation to initiate PrEP.
I would use it [PrEP] because I no longer trusted the 
father of my child before I fell pregnant. He was boring 
and disgusted me. His phone was always busy and I do 
not know what he is doing with other women. I had 
that mentality that he may be sick and I do not know 
what he is doing and when. (GD Females 18–24 years; 
South Africa).
Preventing HIV Acquisition and Desire to Remain 
HIV Negative
Some participants mentioned that the desire to remain HIV 
negative was a potential facilitator to consider PrEP use. 
These participants expressed a willingness to take PrEP 
due to the nature of sexual activities they engaged in or that 
existed in their communities. Most of them viewed PrEP as 
a breakthrough strategy to prevent acquisition of HIV.
I will swallow PrEP because I know that I will not 
contract HIV. I may meet a girl who has every sexu-
ally transmitted disease including HIV but PrEP will 
help me not to get HIV after I have had sex because 
for its case it does not cure. For other STIs, you can 
get medication and recover but not HIV. (GD Males 
13–17 years; Uganda)
Ehhh, honestly guys, to tell the truth, for now this 
[PrEP] is the best thing that we have to stay negative 
and prevent this disease [HIV]. I am sitting here and 
talking about the way I am going to protect myself from 
HIV and that’s for me is like the icing on the cake, 
the cherry on top, seriously. (GD Males 18–24 years; 
South Africa)
PrEP was seen as a safer prevention strategy that would 
build intimacy for those who had difficulty to utilize other 
HIV prevention like condoms. Some participants had con-
cerns and reservations for using condoms such as a decrease 
in sexual pleasure and dislike of condoms by sexual partners 
and viewed PrEP as a possible prevention alternative.
There is a time when my boyfriend drinks a lot. So 
when I go to see him, I know that we will sleep together 
[have sex]. So I believe I will need PrEP, because he 
does not hear my voice when I say let’s use a condom. 
He asks “why now, why do you want a condom?” (IDI 
Female 20 years; South Africa)
Use of condoms will definitely reduce since most peo-
ple use condoms to prevent HIV. So if I get PrEP that I 
can use to prevent HIV infection without using a con-
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Most participants expressed willingness to take PrEP if other 
people especially their peers were taking PrEP. Participants 
acknowledged that they would be inclined to take PrEP if 
they realized others took the pills and nothing happened to 
them after taking PrEP.
The best way for them [peers] to use it is when they see 
me using it…Yaahh, they want protection, they need to 
see me having used it and am alive. Then they will say 
let’s go boys and we get them [PrEP pills] together. (GD 
Males 19–21 years; Zimbabwe)
Social Support and Care for PrEP Uptake
Support, care and encouragement mainly from family, sup-
portive partners and friends were also viewed as an important 
facilitator for PrEP uptake. The participants remarked that 
receiving care and support (financial or material) from imme-
diate family would encourage them to use PrEP.
I think that it’s the circle of friends that we keep that 
should encourage you to take PrEP because the people 
that should care and support you first are your family 
and then your friends because if they don’t support you 
they will think that you are sick and dying and want to 
kill them as well. (GD 18- Females 24 years; South 
Africa).
(3) Community-level facilitators
Adequate PrEP Information and Sensitization
Some participants mentioned that receiving adequate PrEP 
information and sensitization was a prerequisite for taking 
PrEP. Participants shared that information about PrEP needs 
to be disseminated in simple language that people can easily 
understand.
What will make it easy is being well informed so that 
we will have in-depth knowledge that this medica-
tion can prevent us from HIV infection. (GD Males 
13–15 years; Zimbabwe).
Some participants mentioned that when information about 
PrEP is made available, with opportunities to discuss PrEP, 
making it known in the community, then the likelihood of 
PrEP uptake would increase.
Evidence of PrEP Efficacy and Safety
In addition to adequate PrEP information, the participants 
noted that receiving information and evidence that PrEP 
works and is highly effective could facilitate PrEP uptake.
If they notice that people are not dying or if they go to 
people who have used PrEP and they are not affected 
by PrEP or not infected with HIV, young people will 
take it. (IDI Male 23 years; Uganda)
Since many participants were PrEP naïve, they had a 
perception that PrEP was still under experimentation and 
research. They considered that obtaining evidence to show 
that PrEP was safe and effective would encourage PrEP 
uptake. Participants narrated that if they are given examples 




At the institutional level, as in many situations, health care 
services are often at a significant distance from the people, 
some participants mentioned that access to PrEP needed to 
be designed in an adaptive and innovative way, so that many 
young people who would benefit from it and receive PrEP.
If its near let’s say, a government hospital or nearby 
health centers, I would move and go looking for PrEP. 
It will be easy for me when I am getting it [PrEP] from 
near…But if it is in [mentions a distant place], I will 
have to “put in” [incur a cost] transport to go get it yet 
at times we don’t have money. I don’t work money is 
hard to get. (IDI Female 17 years; Uganda)
Provision of PrEP with convenient local access, creation 
of different platforms and PrEP service providers such as 
community health workers who are responsive to provide 
health services to adolescents was a considered a potential 
facilitator of PrEP uptake.
Provision of Appropriate and Sufficiently Resourced 
Services
In relation to convenient and responsive services, participants 
noted that a facilitator to PrEP uptake was for it to be deliv-
ered in an appropriate and sufficiently resourced manner to 
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minimize stock-out challenges, and including provision of 
information and sensitization through promotions and cam-
paigns to support demand creation.
It may be good for dispensing in the clinics so it is easy 
to obtain. If I go to this clinic when it [PrEP] is finished, 
then I can go to another clinic and get it. (IDI Female 
21 years; Uganda).
…I think it requires campaigns to be done in the popu-
lation like you moving around encouraging young 
people to take PrEP and you people telling us why it’s 
good. (IDI Female 21 years; Zimbabwe).
(5) Structural-level facilitators
Access and Availability
Participants reported that having PrEP available in places 
closer to the young people would be a great advantage and a 
facilitator to PrEP uptake.
Let us say that they have initiated PrEP at Entebbe hos-
pital it will be hard to get it but if you distribute it in all 
the communities one can easily get it…It will be easy 
for me to access it if it is in the nearby health centers, 
and I can pick it at any time because sometimes I may 
not be able to walk long distances when I am too busy. 
(GD Males 19–24 years; Uganda).
Linked to provision of appropriate services, accessibility 
and availability were important attributes of PrEP uptake and 
some participants noted that PrEP would be easily used if 
they were comfortable with the way it is delivered as a youth-
friendly service, convenient to obtain and flexible to access.
At least if they manage to use shopping centers which 
are easily accessible for many because no one can say I 
can’t go to the shopping center. Many people always go 
to the shops, in hospitals or near these hospitals people 
can go there. (IDI Male 21 years; Zimbabwe)
Costing of PrEP
Structural facilitators included providing PrEP free of charge. 
For some adolescents and young people in these communi-
ties, providing PrEP as a free service would be a big facili-
tator for PrEP uptake. To these participants, anything that 
comes with a cost is quickly shunned.
I think that they will be happy because no person likes 
to die of AIDS. If they see that the pills are available 
for free they will be happy because some may not get 
money to buy Protector [condom brand] and end up 
having unprotected sex. (GD Females 13–15 years; 
Zimbabwe).
For many AYP, who are often financially vulnerable, 
receiving PrEP at no cost would facilitate its uptake.
Some hospitals can be selling yet others are not selling 
and the one next to you is selling. If you know that you 
are not sick you will say let me go do something else 
with that money and you overlook your health. Person-
ally, if PrEP came and it is not for paying then it will 
be very easy for me. (IDI Female 17 years; Uganda).
Discussion
PrEP as a biomedical HIV prevention strategy can minimize 
HIV acquisition among AYP in sub-Saharan Africa. Under-
standing the barriers and facilitators to PrEP uptake is critical 
to enhance the successful utility of PrEP among AYP. We 
used the social ecological model to explore key barriers and 
facilitators to PrEP uptake among mostly PrEP naïve AYP 
aged 13–24 years in sub-Saharan African settings.
The SEM allowed us to reflect on the interdependent 
nature of our findings at multiple levels and interrelationships 
(McLeroy et al., 1988). Some of the findings were overlapping 
at the different levels of the model. The way AYP responded 
to PrEP as a new biomedical HIV prevention strategy was 
embedded in different structures ranging from individual 
through to structural factors. The findings highlight impor-
tant implications for addressing the barriers and enhancing 
the facilitators to PrEP uptake among AYP at the different 
levels of the SEM.
At the individual level, we found new perspectives on bar-
riers to PrEP uptake compared to the existing literature, such 
as the complexities of timing of taking PrEP and PrEP char-
acteristics. People may be willing to use PrEP, but due to their 
busy schedules may find it difficult to adhere to taking it as 
prescribed, which thus hinders its effective use. For example, 
the fishermen of Lake Victoria may not take PrEP because of 
their mobile lifestyle (Mack et al., 2014). Keeping to a regular 
time for taking PrEP was also a concern for the school going 
children in our study. Our findings further confirm that stigma, 
expected side effects, and pill burden were barriers to PrEP 
uptake, consistent with findings from other studies (Holloway 
et al., 2017; Patel et al., 2016). These are important issues to 
consider for successful PrEP implementation and utilization 
in resource constrained settings where treatment for preven-
tion is not a common practice.
Participants’ perception of HIV risk was a facilitator of 
PrEP uptake and their preference was for on-demand PrEP 
especially when they felt at low risk of HIV and did not want 
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to commit to a daily PrEP regimen. This finding is similar to 
those found in other previous studies among MSM (Lorente 
et al., 2012; Molina et al., 2017). On-demand PrEP would 
address their concerns over daily use and possible adherence 
challenges in the context of not having routine schedules.
Our study unpacks other PrEP characteristics and proper-
ties including the cost of PrEP as a potential barrier to uptake. 
Additionally, the size, taste and smell of PrEP pills should be 
considered alongside the favorable properties of PrEP agents 
(safety, tolerability and long-lasting activity with convenient 
dosing) in developing the next generation PrEP to make PrEP 
attractive and convenient to use by the intended end users 
(Abraham & Gulick, 2012).
The findings highlight important implications for PrEP 
uptake among AYP at the interpersonal level. Most partici-
pants were under the care of their parents/caregivers or were 
in a relationship, therefore could not easily make independent 
decisions and also had a lack of privacy. Even though most 
would have been willing to take PrEP, they felt restricted, 
including the fear of being discovered as sexually active by 
their parents. This suggests that systemic introduction of 
PrEP to the community and sensitization of key stakeholders 
(parents, peer leaders and other influential people in the com-
munity) to solicit for their advocacy and promotion of PrEP 
for HIV prevention is important (Shah et al., 2019). This 
would thus enable adolescents and young people to embrace 
the use of PrEP as an HIV prevention measure.
Our results also revealed peer influence as an important 
facilitator of PrEP uptake, alongside social support. Partici-
pants noted that PrEP was coming in at a time when many 
AYP felt that other biomedical HIV prevention strategies 
were not suitable for the adolescent population. It is impera-
tive to note that decreased HIV risk perception has been asso-
ciated with poor adherence and low interest in prevention 
interventions such as PrEP or microbicides and has the poten-
tial to increase risky sexual behaviors (Pettifor et al., 2013).
Our findings showed existing misconceptions about PrEP 
at the community level, which were perceived as a poten-
tial obstacle to uptake. Previous studies among transgen-
der adolescents and at-risk populations in Peru and Kenya 
found similar results (Fisher, Fried, Desmond, Macapagal, 
& Mustanski, 2017; Galea et al., 2011; Mack et al., 2014). 
Many AYP may be discouraged by the community reflec-
tions on the prospect of potential medication side effects and 
the skepticism of PrEP use in relation to its efficacy to pre-
vent infection as reflected in a previous study in France and 
Canada among MSM (Molina et al., 2017). We recommend 
providing adequate information and sensitization for commu-
nities, including AYP, on PrEP efficacy and safety that is still 
limited in this setting but will importantly facilitate informed 
decision making on PrEP uptake. Our research group is cur-
rently conducting a clinical trial to evaluate the efficacy and 
safety of different PrEP drugs (oral Emtricitabine/ Tenofo-
vir Disoproxil Fumarate and oral Emtricitabine/Tenofovir 
Alafenamide), including timing of doses, among young peo-
ple 13–24 years in Uganda and South Africa. Community-
based approaches to PrEP sensitization and roll-out, such 
as community education campaigns, may be an important 
step toward reducing PrEP barriers and achieving increased 
PrEP acceptance levels by enhancing the facilitators (Golub 
et al., 2017).
At the institutional level, the lack of training in PrEP provi-
sion and negative attitudes toward PrEP can influence health 
worker perspectives, prejudicial beliefs and PrEP provision to 
AYP. Therefore, the utilization of non-prescribing providers 
can help overcome the institutional barriers to PrEP uptake 
(Pinto, Berringer, Melendez, & Mmeje, 2018).
It should be noted that AYP expressed willingness to take 
PrEP once provided at a service that is low cost, regularly 
available and easily accessible, suggesting that PrEP provi-
sion should be tailored for AYP at the structural level (Yakob 
& Ncama, 2016). Other studies have shown that cost and 
access are major barriers for PrEP uptake among other popu-
lations (Pérez-Figueroa, Kapadia, Barton, Eddy, & Halkitis, 
2015; Young et al., 2014). Making pill access and pickup 
points more reachable will make PrEP more widely available 
and can help to mitigate concerns of failing to reach for the 
pills when needed.
Overall, the majority of participants welcomed the con-
cept of PrEP and were curious to know when it will be rolled 
out. PrEP as a breakthrough HIV prevention strategy for the 
AYP relates to the empowerment, autonomy and discreet-
ness PrEP provides to adolescents in relation to HIV preven-
tion. This is critical in sub-Saharan Africa settings where 
intergenerational sex among AYP is common and associated 
with reduced ability to negotiate safe sex, low condom use, 
unsafe sexual behavior that increases the risk of HIV infec-
tion (Luke, 2003). The high HIV prevalence rates among 
AYP in sub-Saharan Africa highlight the urgent need for 
effective and targeted PrEP strategies (Baeten et al., 2012; 
Shisana et al., 2014). Therefore, addressing the identified 
barriers of PrEP uptake in this underserved population is 
critical (Bekker & Hosek, 2015).
These study findings offer new perspectives into the likely 
barriers and facilitators to PrEP uptake among PrEP naïve 
adolescents and young people in sub-Saharan Africa and 
future studies should examine how the barriers and facilita-
tors at the different levels of the SEM affect adherence when 
PrEP is rolled out among AYP (Pinto et al., 2018).
Study limitations include the study being conducted in 
PrEP naïve communities where the concept of PrEP was 
confused with other constructs like school study/reading 
time, and post-exposure prophylaxis. As the study partici-
pants were PrEP naïve, we identified perceptions rather than 
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actual behavior in a non-treatment study population. Simi-
larly, despite our large sample we did not carry out compara-
tive analyses by age, gender and country which are crucial 
areas for future research. However, our findings provide 
important insights into potential barriers and facilitators of 
PrEP uptake among AYP in low-resource settings. Future 
studies in our context need to evaluate the potential barriers 
and facilitators to PrEP uptake from service providers that 
provide adolescent-friendly services, healthcare workers and 
policy makers perspectives.
In summary, there is a range of barriers and facilitators 
that would affect PrEP uptake. When addressed, PrEP will 
serve as an additional HIV prevention strategy for AYP 
who are potential PrEP users (Bekker & Hosek, 2015). The 
development of appropriate youth-friendly services and pro-
grams providing free or inexpensive quick access using vari-
ous platforms and providers with minimal PrEP stock-out, 
friendly health worker contact, privacy and confidentiality 
will support PrEP uptake and utilization. Additionally, pro-
viding information and mitigating the barriers at all levels 
will encourage PrEP uptake and eventual adherence. Future 
multi-level interventions should consider the social and 
structural drivers when designed and focus on ways that can 
inspire PrEP uptake and limit the barriers.
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